Potentiation of Bradykinin Effect by Angiotensin-Converting Enzyme Inhibition Does Not Correlate With Angiotensin-Converting Enzyme Activity in the Rat Mesenteric Arteries
Authors:
- 1 July 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 50 (1) , 110-115
Abstract
Angiotensin-converting enzyme (kininase II [ACE]) inhibitors are capable of potentiating bradykinin (BK) effects by enhancing the actions of bradykinin on B2receptors independent of blocking its inactivation. To investigate further the importance of ACE kininase activity on BK-induced vasodilation, we investigated the effect of inhibiting ACE, as well as other kininases, on both BK metabolism and vasodilator effect in preparations that exhibit increased ACE activity. Mesenteric arterial beds obtained from 1-kidney, 1-clip hypertensive rats presented augmented ACE and angiotensin I converting activities compared with normotensive rats. The isolated and perfused mesenteric beds were exposed to BK for 15 minutes in the absence or in the presence of kininase inhibitors; then, the perfusate was collected for analysis of the products of BK metabolism by high-performance liquid chromatography. BK was metabolized to the fragments BK(1-8), BK(1-7), and BK(1-5), and the recovery of intact BK was reduced by 47% in the hypertensive group. Recovery of BK was increased in both groups in the presence of a kininase I inhibitor and in the hypertensive group by neutral endopeptidase 24.11 inhibitor; however, ACE inhibition did not affect BK metabolism in both groups. In contrast, only the ACE inhibitor potentiated the vasodilator effect of BK in a mesenteric bed preconstricted with phenylephrine; the increase in BK effect, nevertheless, was not greater in arteries from hypertensive rats that presented an increased ACE activity when compared with those in the normotensive group. These data demonstrated that ACE inhibitor–induced potentiation of BK vasodilator effects is not related to their actions on BK degradation.Keywords
This publication has 22 references indexed in Scilit:
- Human ACE and bradykinin B 2 receptors form a complex at the plasma membraneThe FASEB Journal, 2006
- Bradykinin potentiation by ACE inhibitors: a matter of metabolismBritish Journal of Pharmacology, 2002
- Neuropeptide Specificity and Inhibition of Recombinant Isoforms of the Endopeptidase 3.4.24.16 Family: Comparison with the Related Recombinant Endopeptidase 3.4.24.15Biochemical and Biophysical Research Communications, 1998
- Clinical trials: what more is needed? A critical viewJournal Of Hypertension, 1996
- The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive ratsJournal Of Hypertension, 1993
- Increased vascular formation of angiotensin II in one-kidney, one clip hypertension.Hypertension, 1992
- Bradykinin-Degrading Enzymes: Structure, Function, Distribution, and Potential Roles in Cardiovascular PharmacologyJournal of Cardiovascular Pharmacology, 1992
- A survey of vasoactive peptide metabolizing enzymes in the rat mesenteric arterial bed perfusateBiochemical Pharmacology, 1991
- Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivoKidney International, 1987
- BRADYKININ‐INDUCED RELAXATION OF RENAL AND PULMONARY ARTERIES IS DEPENDENT UPON INTACT ENDOTHELIAL CELLSBritish Journal of Pharmacology, 1981